My name is Monir El Azzouzi and I am a Medical Device Expert specialized in Quality and Regulatory affairs. And on this podcast I will help you place compliant medical devices on the market. For that I will share with you my knowledge or the one of others through discussion or interviews. I will invite experts in the area to tell you what you can do or the challenges you may encounter.
This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.
Site
RSS
Apple
Données mises à jour le 17/10/2026
Classements récents
Dernières positions dans les classements Apple Podcasts et Spotify.
Liens partagés entre épisodes et podcasts
Liens présents dans les descriptions d'épisodes et autres podcasts les utilisant également.
AI Agents for Your Medical Device Business: Where Do You Start?
Épisode 411
jeudi 15 octobre 2026 • Durée 55:18
Small Business, Smart Start: AI Without Complex Infrastructure
Artificial Intelligence is creating new opportunities for businesses to improve productivity, simplify workflows, and reduce repetitive administrative work.
However, for many small medical device companies, adopting AI can feel overwhelming.
Where should you begin? Which processes are worth automating? Do you need expensive infrastructure or a dedicated development team? And how can you ensure that an AI assistant delivers reliable results?
In this episode of Medical Device Made Easy, we welcome Helder Conceicao to explore how small businesses can take their first practical steps with AI agents.
With experience in service engineering, business processes, and supporting AI adoption in small companies, Helder brings a practical perspective to a topic that is often presented as more complicated than it needs to be.
Understanding AI Agents: Beyond Traditional Chatbots
Many professionals have already experimented with AI tools to answer questions, draft emails, or summarize information.
But an AI agent introduces a different way of thinking about how AI can support business processes.
Rather than focusing only on individual conversations, the discussion explores how AI assistants can support defined tasks and workflows.
Helder explains the differences between traditional chatbots and AI agents, including what these solutions can accomplish and where human involvement remains necessary.
The objective is to help business owners understand the practical possibilities before investing in a solution.
Choosing the Right First AI Project
One of the biggest challenges in AI adoption is deciding where to begin.
Businesses may have dozens of processes that could potentially benefit from automation, but not every task is a good starting point.
The conversation explores how to identify a first project based on a genuine operational need.
For medical device companies, potential areas to investigate include:
Documentation: Supporting document preparation, organization, and information retrieval.
Quality and Regulatory Affairs: Assisting with administrative activities and information management while maintaining appropriate human review.
Field Service: Exploring ways to support service-related workflows and routine processes.
The key is to identify a manageable use case with a clear purpose and measurable value.
From an Idea to a Working AI Assistant
Once a company has identified a suitable process, what happens next?
The episode explores the journey from an initial business problem to a functioning AI solution.
This includes understanding what information the company needs to prepare, how the workflow should operate, and what technical resources may be required.
An important part of the discussion is determining whether an existing AI platform can meet the company's needs or whether additional development and infrastructure are necessary.
For smaller organizations, these decisions can have a significant impact on project complexity, cost, and implementation time.
How Much Does AI Implementation Really Require?
Cost and resources are common concerns for businesses considering AI.
Does every AI project require a large budget? How much time should the company expect to invest? And how involved does the internal team need to be?
Helder discusses the practical considerations behind planning an AI implementation, including the importance of defining the project's scope and understanding the resources required.
The goal is to help businesses approach AI adoption with realistic expectations rather than assuming that every solution requires a major technology investment.
Keeping Humans in Control
For medical device companies, automation must be considered alongside reliability, accountability, and appropriate oversight.
Not every task should be delegated to AI without review.
The conversation addresses how to determine which activities an AI assistant can support independently and which require a qualified person to review, approve, or make the final decision.
It also explores how businesses can test whether an AI assistant is sufficiently reliable for its intended task, particularly when working with important company documents.
AI should support better business processes without removing necessary human judgment and responsibility.
Measuring the Value of Your First AI Project
Implementing an AI assistant is only the beginning.
The next question is whether the solution actually improves the business process it was designed to support.
The discussion examines common challenges encountered during initial AI projects and how businesses can evaluate their results.
Potential considerations include time saved, reduced repetitive work, improved workflow efficiency, and the level of human intervention still required.
Understanding these outcomes can help a company decide whether to improve its first solution or move toward another use case.
Building Independence and Long-Term Capability
An AI solution should not necessarily leave a company dependent on the person who originally developed it.
The episode also explores the importance of documentation, knowledge transfer, and ongoing support.
Helder discusses how businesses can understand the solutions implemented for them, how they may operate those solutions independently, and what additional assistance could be available after deployment.
This is particularly relevant for small companies that want to develop their internal capabilities while keeping their technology manageable.
Final Takeaway: Start Small, Learn, and Expand
AI adoption doesn't have to begin with a company-wide transformation.
For small medical device businesses, a useful first step is to identify one process that consumes time, creates repetitive work, or could benefit from better information management.
Then explore whether an AI assistant can help.
Start with a clear problem. Build a focused solution. Test the results. Keep people involved where necessary. Measure the value.
Once the first project demonstrates its usefulness, the company can consider what comes next.
In this episode of Medical Device Made Easy, Helder Conceicao helps make the first steps toward AI adoption more understandable and practical for small businesses.
What is one business task you would like AI to help you improve?
Who is Helder Conceição?
Helder Conceição is the founder of heconexus®, helping small businesses in Portugal adopt AI in their everyday work. He brings more than 25 years of experience at Johnson & Johnson across local, European and global roles, spanning service engineering, business processes and digital initiatives. His approach focuses on practical processes, measurable value, human oversight and helping teams become confident and autonomous in their use of AI.
This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.
Medical Device Regulatory Update – October 2026
Épisode 410
vendredi 9 octobre 2026 • Durée 26:03
October brings another important round of regulatory developments for the medical device and IVD industry. From updated IVD classification guidance in Europe and potential changes to the UK medical device licensing framework, to new FDA expectations for robotically assisted surgical devices, radiology AI, PMA submissions, and international regulatory reliance, manufacturers have several developments worth following closely.
Here is our Medical Device Regulatory Update for October 2026, supported by regulatory intelligence from MedBoard.
🇪🇺 European Union – Revised IVD Classification Guidance
The European Commission has published MDCG 2020-16 Rev.5, updating the guidance on classification rules for in vitro diagnostic medical devices under the IVDR.
For IVD manufacturers, classification is a fundamental regulatory decision that can affect the conformity assessment route and regulatory strategy.
Proposed amendments to the UK Government's Health Bill could create powers supporting the future development of a medical device licensing regime.
The amendments also address information-sharing powers for medicines and medical devices and measures intended to make medicines and medical-device legislation easier to update.
This is an important development to watch for manufacturers planning access to the UK market.
AI Is Already Inside Your QMS — But Is It Under Control?
Épisode 409
jeudi 1 octobre 2026 • Durée 28:35
Artificial Intelligence may already be part of your Quality Management System, even if your organization has never formally implemented an AI tool.
Regulatory Affairs professionals may use ChatGPT to research requirements. Quality teams may use AI to help draft procedures or summarize meetings. Engineers may ask AI to brainstorm potential failure modes. Post-Market Surveillance teams may experiment with AI to analyze complaints.
This creates an important challenge:
AI may already be inside your QMS—even though your QMS doesn't know it. Markdown collé
The answer isn't necessarily to ban AI.
The answer is to understand where it is being used and introduce controls proportionate to the risk.
The Shadow AI Problem
Employees don't always wait for management to formally implement AI.
When a tool can turn a three-hour activity into a thirty-minute task, people naturally become interested.
The Quality challenge isn't simply that AI is being used. The problem is that the organization may not know:
what activities AI supports, what information employees provide to it, how outputs are verified, and how heavily people rely on those outputs.
This is what the episode describes as Shadow AI. Markdown collé
Not Every AI Use Has the Same Risk
Asking AI to improve the wording of an email isn't equivalent to asking it to determine whether complaint data indicates a safety signal.
The key question is:
What happens if the AI is wrong?
An error in a rewritten email may have limited consequences. An incorrect conclusion about complaint reportability or patient safety could have significantly different consequences.
AI governance should therefore be based on intended use and risk, rather than treating every AI application identically. Markdown collé
Vertical Slicing for Complex SaMD Development
Épisode 408
jeudi 24 septembre 2026 • Durée 28:09
Developing complex Software as a Medical Device (SaMD) can quickly become challenging.
Requirements, software architecture, dependencies, risk management, verification, regulatory evidence, and cross-functional collaboration all need to work together.
But what happens when individual software components appear to work correctly while the complete end-to-end workflow reveals something different?
In this episode of the Easy Medical Device Podcast, Monir El Azzouzi welcomes Shreya Sridhar from Medtronic to explore vertical slicing for complex regulated software products.
Rather than looking at a system only through individual components or technical layers, vertical slicing provides a way to examine functionality end-to-end.
In this episode, we discuss:
🔹 What vertical slicing means in practice 🔹 The challenges of developing complex SaMD 🔹 How end-to-end workflows can reveal hidden problems 🔹 How to structure vertical slices 🔹 Integrating vertical slicing into Agile development 🔹 Risk management, verification, and regulatory evidence 🔹 Vertical slicing alongside Design Controls 🔹 Cross-functional collaboration in regulated development 🔹 What “Done” means for a vertical slice in a medical device environment 🔹 The potential role of vertical slicing as AI supports requirements, code, testing, and documentation 🔹 Practical advice for teams that want to start using the approach
The conversation connects software development with the realities of regulated medical device development, looking beyond whether individual components work to understand whether the complete functionality works as intended.
Why Management Doesn’t Listen to Quality—and How to Change That
Épisode 407
jeudi 17 septembre 2026 • Durée 56:41
Quality and Regulatory professionals often find themselves in a frustrating position.
They identify a problem, explain the compliance risk and recommend an action. But instead of being seen as protecting the organization, they can become perceived as the people creating obstacles.
Operations sees a delayed project. Finance sees additional resources. Management sees another problem that needs to be solved.
Over time, this dynamic can leave QA/RA professionals frustrated, isolated and exhausted.
But the problem isn't always management.
Sometimes, the way Quality operates can unintentionally contribute to that isolation.
When Quality Owns Everything
Consider a nonconformity that occurs in Production.
In some organizations, Quality opens the record, writes the description, gathers the evidence, conducts much of the investigation, pushes for the root cause, proposes the corrective action and follows the issue until closure.
The problem happened in Production—but Quality performed almost all the work.
The organization eventually learns a dangerous lesson:
“When something goes wrong, send it to Quality.”
This creates dependency instead of ownership.
Your Technical Documentation Has All the Documents… So Why Isn't It Ready?
Épisode 406
jeudi 10 septembre 2026 • Durée 38:08
A company says its Medical Device Technical Documentation is 90% or 95% ready.
The Risk Management File exists. The Clinical Evaluation is complete. Testing has been performed. The GSPR checklist and IFU are available.
But there's an important question:
95% of what?
Having all the expected documents doesn't necessarily mean your Technical Documentation is ready for assessment. Like a puzzle, you can have every piece on the table—but if some pieces are outdated, others belong to a different version of the product, and several don't fit together, the puzzle isn't complete.
1. Start With the Product, Not Annex II
Instead of immediately opening an Annex II template and looking for documents to fill each section, start with a more fundamental question:
What exactly are we trying to certify?
Your intended purpose, patient population, intended users, use environment, indications, contraindications, lifetime, claims, variants and accessories should provide a common source of truth across the Technical Documentation.
If Marketing makes a claim that isn't reflected in the intended purpose, Clinical Evaluation or Risk Management File, you may already have a significant consistency problem.
2. Challenge Your Regulatory Assumptions
Medical Device Regulatory Update: July & August 2026
Épisode 405
mercredi 2 septembre 2026 • Durée 43:35
Medical device regulation continues to evolve across multiple markets. For manufacturers, the challenge isn't simply following every new publication—it's understanding which developments require action, which ones need monitoring, and how they affect existing regulatory strategies.
This latest Medical Device Made Easy regulatory update reviews selected developments from July and August 2026 across Europe, Switzerland, the UK, United States, India, Singapore, and Brazil.
🇪🇺 UDI Assignment Under Distributor Branding
Read MDCG 2026-5 – UDI Assignment
MDCG 2026-5 addresses situations where the same medical device is sold under both the manufacturer's brand and a distributor's brand.
Different UDI-DIs may be appropriate, but when the original manufacturer remains the legal manufacturer, the codes must remain assigned by and linked to that manufacturer. This makes existing private-label arrangements, UDI structures, EUDAMED records, and agreements worth reviewing.
🇪🇺 Notified Body Certification & Fee Transparency
Team-NB MDR Certification Process v2.1
European Commission Notified Body Fee Directory
Team-NB's updated consensus paper maps the MDR certification journey from pre-application and quotation through conformity assessment, certification, and surveillance.
Combined with the European Commission's consolidated directory of Notified Body fee pages, these resources can help manufacturers better understand both the certification process and the costs that need to be considered when planning market access.
From Verification & Validation to Global Market Access | V&V, DHF & IMDRF
Épisode 404
jeudi 27 août 2026 • Durée 31:54
Developing a medical device successfully requires several pieces to work together. Manufacturers must demonstrate that the product meets its requirements, maintain reliable design documentation, and understand how regulatory expectations differ—or increasingly align—across global markets.
In this Easy Medical Device podcast collection, we explore three connected topics that represent different stages of this journey: Verification & Validation, Design History File remediation, and IMDRF and regulatory reliance.
Making Verification & Validation Practical
Verification and Validation are fundamental parts of medical device development, but the distinction between them can sometimes create confusion.
Verification focuses on whether the device has been developed according to defined requirements, while validation considers whether the resulting device meets its intended use and user needs.
Understanding how to plan and execute V&V effectively helps manufacturers build stronger evidence around device performance and supports a more structured development process.
When Your Design History File Needs Remediation
What happens when the product has already been developed, but the Design History File doesn't properly demonstrate the development journey?
DHF remediation can become necessary when documentation is incomplete, fragmented, poorly traceable, or does not adequately demonstrate how design controls were applied.
The discussion explores the importance of rebuilding those connections and creating documentation that clearly demonstrates the relationship between requirements, design activities, V&V evidence, risk management, and design decisions.
Bringing a medical device to market requires more than achieving regulatory approval. The decisions made early in product development can influence classification, clinical evidence, risk management, labeling, identification, and ultimately the entire market access strategy.
In this Easy Medical Device podcast collection, we focus on two important regulatory topics: defining a proper Intended Use and understanding Master UDI-DI.
Intended Use: The Foundation of Your Regulatory Strategy
Intended Use may look like a simple statement, but it can influence almost every part of a medical device's regulatory pathway.
A poorly defined Intended Use can create downstream problems with device classification, clinical evaluation, risk management, and regulatory submissions.
Even small changes in wording can have significant consequences, particularly for areas such as Software as a Medical Device (SaMD).
The discussion also explores a common misconception: manufacturers cannot simply use a disclaimer or change their labeling to avoid medical device regulation when the actual intended purpose and claims bring the product within the medical device framework.
Understanding Master UDI-DI
Device identification is another increasingly important part of regulatory strategy.
Master UDI-DI introduces an additional layer that MedTech manufacturers need to understand when managing device identification and regulatory information.
Building a Strong Quality Management System: From Documentation to Real Compliance
Épisode 402
mercredi 12 août 2026 • Durée 34:41
Having an ISO 13485 Quality Management System in place does not automatically mean that your quality processes are effective.
A strong QMS should help an organization identify problems, evaluate their significance, capture information from the market, investigate systemic issues, and continuously improve.
In this Easy Medical Device podcast collection, we examine several situations that can reveal whether a QMS is truly functioning—or simply looks good on paper.
Understanding NC vs CAPA
One of the most misunderstood areas of quality management is determining when to open a Nonconformity and when to escalate an issue into a CAPA.
Not every isolated problem requires a complete CAPA investigation. However, when an issue becomes recurring, systemic, significant, or potentially high-risk, a deeper investigation may be necessary.
The objective isn't to create as many CAPAs as possible. It's to recognize the problems that genuinely require root cause investigation and corrective action.
Why “We've Never Had a Complaint” Can Be Dangerous
Zero complaints may sound like excellent news, but it can also raise an important question:
Is your organization effectively capturing all sources of customer and post-market feedback?
Potential complaints may appear through distributor communications, service reports, customer emails, returned products, training feedback, or other customer-facing channels.
If this information isn't properly evaluated, the organization may miss important product performance or safety signals.
The Fake QMS Problem
A Quality Management System can look excellent on paper.
Procedures exist. Forms are available. CAPA processes are defined. Risk management documentation is complete.
But if employees don't follow those processes in daily operations, the QMS can become disconnected from reality.
🇬🇧 MHRA Warning – Incompatible Components Continue to Cause Serious Incidents
The MHRA has highlighted ongoing safety concerns involving patient hoists and incompatible components.
The warning is an important reminder that medical-device safety does not stop with individual component compliance. Compatibility between components, accessories and systems can directly affect patient safety.
Manufacturers and healthcare organizations should pay close attention to compatibility information, instructions for use and the way devices are combined in real-world environments.
🇨🇭 swissdamed – Importer Linking Is Now Operational
Another important development comes from Switzerland.
Swiss importers can now link their CHRN to imported devices in swissdamed.
This adds another operational consideration for manufacturers and importers working in the Swiss medical-device market, particularly as swissdamed becomes increasingly important within the country's regulatory infrastructure.
The FDA has issued draft guidance addressing robotically assisted surgical devices.
The guidance covers areas including non-clinical testing, clinical evidence and labeling for teleoperated surgical systems.
For manufacturers developing robotic surgical technologies, understanding these expectations early can help inform development, testing and premarket strategy.
🌐 FDA Creates a Regulatory Reliance Resource Centre
International regulatory reliance continues to gain attention.
The FDA has created a dedicated CDRH Regulatory Reliance Portal explaining how other regulatory authorities can leverage FDA regulatory work and decisions while retaining their own national sovereignty and decision-making responsibilities.
For an increasingly global medical-device industry, regulatory reliance could play an important role in reducing unnecessary duplication and supporting more efficient regulatory processes.
Alongside this month's regulatory developments, Easy Medical Device continues to expand the resources and services available to medical-device companies.
EasyIFU
EasyIFU supports medical-device manufacturers working with electronic Instructions for Use.
New partner services are also available in areas including:
Software Development & Cybersecurity
Company Creation
These services expand the support available to medical-device companies across different stages of their development and market-access journey.
🎙️ Latest Easy Medical Device Podcast Episodes
October is also a good opportunity to catch up on the latest Medical Device Made Easy episodes.
Episode 406 – Your Technical Documentation Has All the Documents… So Why Isn't It Ready?
Having every document does not necessarily mean your Technical Documentation is assessment-ready. This episode explores adequacy, consistency, evidence and traceability across the dossier.
Episode 407 – Why Management Doesn't Listen to Quality and How to Change That
Why do Quality and Regulatory teams sometimes become isolated from the rest of the organization? This episode explores the shift from being the “Quality Police” to becoming a Quality Influencer.
Episode 408 – Vertical Slicing for Complex SaMD Development
Complex SaMD development can become fragmented when teams focus on individual components. This conversation explores vertical slicing as a way to look at functionality and clinical workflows end-to-end.
Episode 409 – AI Is Already Inside Your QMS – But Is It Under Control?
AI may already be used by Quality, Regulatory, Engineering and PMS teams—even without a formal company-wide AI initiative.
This episode discusses Shadow AI, risk-based AI control, verification, human accountability and how Quality teams can approach AI without simply banning it.
This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.
Green, Amber, Red: A Practical AI Framework
The episode introduces a simple traffic-light approach.
🟢 Green — Assist
AI improves productivity without materially driving a regulated decision.
Examples include improving English, formatting documents, brainstorming, summarizing meeting notes or helping structure a presentation.
Normal human review, together with appropriate confidentiality and information-security controls, may be sufficient for these lower-risk applications.
🟠 Amber — Verify
AI begins influencing regulated work.
Examples include helping draft an SOP, suggesting potential FMEA failure modes, summarizing complaints, researching regulatory requirements or suggesting possible CAPA root causes.
The principle here is simple:
AI can propose. A qualified person must verify.
AI can help locate information, but it shouldn't automatically become the regulatory evidence supporting a decision.
🔴 Red — Assess Before Deployment
Here, AI makes or materially drives a critical decision.
Examples could include automatically determining complaint reportability, accepting suppliers, closing CAPAs, deciding risk acceptability or generating clinical conclusions without independent qualified evaluation.
These uses call for formal assessment before the organization relies on the system. Markdown collé
Human Review Is Not Automatically Verification
“We have a human reviewing everything” sounds reassuring.
But what does review actually mean?
Generative AI can produce incorrect information that looks professional and convincing. Reading an AI-generated regulatory assessment and thinking “looks good” isn't necessarily meaningful verification.
The episode proposes another important principle:
Trust the source, not the sentence.
Regulatory requirements should be checked against the regulation. Complaint-analysis results should be checked against the underlying data and methodology. Technical suggestions should be evaluated by qualified personnel. Markdown collé
Five Steps for Bringing AI Under Control
Rather than immediately writing an AI SOP, the episode recommends starting with discovery.
First, inventory where AI is already being used.
Then classify each use according to what could happen if the output is wrong.
Next, control the input, particularly where patient information, complaints, confidential drawings, clinical data, intellectual property or supplier information may be involved.
After that, define how the output will be verified.
Finally, maintain human accountability.
As the episode puts it:
“AI can perform work. It cannot inherit your regulatory accountability.” Markdown collé
What About AI Validation?
Instead of starting with:
“Do we need to validate ChatGPT?”
Start by asking:
What exactly are we using it for?
Then:
What happens if it gives us the wrong answer?
And finally:
What level of assurance do we need for that intended use?
The framework presented in the episode is:
Intended Use → Risk → Control → Evidence. Markdown collé
AI Literacy Matters Too
AI governance isn't only about procedures and technical controls.
People need to understand what AI does well, where it can fail, how errors and hallucinations can occur, how information should be verified, what data they are allowed to enter, and when AI should not be relied upon.
That's a much more practical form of AI literacy than simply asking employees to click through another annual training presentation. Markdown collé
AI Isn't the Enemy of Quality
The message of the episode isn't to avoid AI.
Quite the opposite.
AI could create significant opportunities for Quality and Regulatory teams—from supporting complaint analysis and regulatory intelligence to identifying recurring CAPA themes, simplifying procedures, creating training exercises, checking Technical Documentation for inconsistencies, and brainstorming potential hazards for qualified professionals to assess. Markdown collé
The role of Quality shouldn't be to stand in front of innovation and say:
“No, because compliance.”
It should be to enable innovation with appropriate controls.
Final Takeaway
Instead of asking your team:
“Are you using ChatGPT?”
Ask:
“Show me where AI is helping you do your job today.”
Then build the inventory and ask what happens if the AI gets each task wrong.
Green: Assist. Amber: Verify. Red: Assess before deployment.
Control the inputs. Verify the outputs. Keep humans accountable.
Because banning AI may not stop its use, while ignoring it means losing visibility.
This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.
Who is Shreya Sridhar?
Shreya Sridhar is a Principal Systems Engineer and technical leader specializing in complex Software as a Medical Device (SaMD) and AI-enabled medical technologies. Her work focuses on systems architecture, requirements, risk management, verification, and cross-functional product development. She has published and presented on systems engineering, vertical slicing, and the development of complex regulated software, with a particular focus on connecting product strategy to end-to-end engineering execution.
Who is Monir El Azzouzi?
Monir El Azzouzi is the founder and CEO of Easy Medical Device a Consulting firm that is supporting Medical Device manufacturers for any Quality and Regulatory affairs activities all over the world. Monir can help you to create your Quality Management System, Technical Documentation or he can also take care of your Clinical Evaluation, Clinical Investigation through his team or partners. Easy Medical Device can also become your Authorized Representative and Independent Importer Service provider for EU, UK and Switzerland.
Monir has around 16 years of experience within the Medical Device industry working for small businesses and also big corporate companies. He has now supported around 100 clients to remain compliant on the market. His passion to the Medical Device filed pushed him to create educative contents like, blog, podcast, YouTube videos, LinkedIn Lives where he invites guests who are sharing educative information to his audience. Visit easymedicaldevice.com to know more. If you need help implementing QMSR or preparing your teams for FDA inspections, contact: info@easymedicaldevice.com
If you are located outside the EU/UK/Switzerland and need an Authorized Representative (and possibly an Importer), we can support you as well.
This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.
A better principle is:
Ownership stays with the process owner. Quality provides the framework and the challenge.
The Quality Tyrant, Invisible Manager and Influencer
Under pressure, QA/RA professionals can fall into three different behaviours.
The Quality Tyrant tries to create compliance through control. They take over investigations, impose solutions and attempt to own every decision.
The Invisible Quality Manager moves in the opposite direction. They avoid difficult conversations, accept weak justifications and may close issues before they have been properly understood.
The Quality Influencer takes a different approach.
They involve the people closest to the process, separate facts from assumptions, challenge weak root causes, verify that actions address the actual problem and keep responsibility with the process owner.
Quality Shouldn't Be the Human Shield During an Audit
Another sign of an ownership problem appears when an auditor asks Production a question—and everyone immediately looks at the Quality Manager.
A mature QMS isn't demonstrated by how well Quality can answer every question.
It's demonstrated by how naturally employees can explain and perform their own activities.
When the auditor asks about Purchasing, Purchasing should answer. When the question concerns Production, Production should explain the process.
Quality can coordinate, clarify requirements and help locate evidence—but it shouldn't become a human shield between the auditor and the organization.
Training Completion Isn't the Same as Competence
A dashboard showing 100% training completion looks reassuring.
But what does an electronic acknowledgement actually prove?
It proves that someone acknowledged the document—not necessarily that they understood the change or can perform the activity correctly.
Training methods should therefore be proportionate to the activity, its complexity and its risk. Depending on the situation, competence might require a discussion, scenario-based questions or practical demonstration rather than another signature.
Stop Creating Procedures for an Imaginary Company
Quality can also lose credibility by designing processes that the organization cannot realistically operate.
More signatures, approvals, meetings and forms don't automatically create a stronger QMS.
Patient safety, product performance and legal requirements are non-negotiable—but QA/RA professionals also need to distinguish between a genuine requirement and a preferred way of meeting that requirement.
An effective approach understands the regulatory objective and works with the organization to find a practical, proportionate and defensible way to achieve it.
From Quality Police to Quality Influencer
Management doesn't make decisions using regulatory language alone.
Simply saying “Clause X requires us to do this” may be technically correct, but it doesn't always help decision-makers understand the impact.
An influential QA/RA professional translates regulatory concerns into consequences management can evaluate.
Influence starts when people understand how a Quality concern affects the objective they're trying to achieve.
Bring Options, Not Only Obstacles
Management meetings are decision-making environments.
When possible, Quality should explain the problem, identify the non-negotiable regulatory or safety boundaries, and present possible paths forward.
Some situations allow different compliant approaches. Others don't: a legal obligation doesn't become optional because the project is late, and an unacceptable safety risk cannot simply be accepted because fixing it is expensive.
The role of QA/RA is to inform, warn and guide, while escalating appropriately when necessary.
Quality Is a Collective Responsibility
When one Quality professional becomes the author of every nonconformity, owner of every CAPA, coordinator of every audit, author of every procedure and reminder system for every overdue action, burnout becomes almost inevitable.
The solution isn't another time-management technique.
It's moving from individual dependency to collective ownership.
Quality should build the system, support the people operating it, challenge the evidence and monitor effectiveness. But the organization must own the activities that actually create product quality.
Final Takeaway
The goal of QA/RA isn't to win every argument, become the most feared department or keep every dashboard green.
The goal is to improve the quality of the organization's decisions.
Don't become the Quality Tyrant.
Don't disappear as the Invisible Quality Manager.
Become the Quality Influencer who connects regulatory expectations, patient safety and business reality.
Who is Monir El Azzouzi?
Monir El Azzouzi is the founder and CEO of Easy Medical Device a Consulting firm that is supporting Medical Device manufacturers for any Quality and Regulatory affairs activities all over the world. Monir can help you to create your Quality Management System, Technical Documentation or he can also take care of your Clinical Evaluation, Clinical Investigation through his team or partners. Easy Medical Device can also become your Authorized Representative and Independent Importer Service provider for EU, UK and Switzerland.
Monir has around 16 years of experience within the Medical Device industry working for small businesses and also big corporate companies. He has now supported around 100 clients to remain compliant on the market. His passion to the Medical Device filed pushed him to create educative contents like, blog, podcast, YouTube videos, LinkedIn Lives where he invites guests who are sharing educative information to his audience. Visit easymedicaldevice.com to know more. If you need help implementing QMSR or preparing your teams for FDA inspections, contact: info@easymedicaldevice.com
If you are located outside the EU/UK/Switzerland and need an Authorized Representative (and possibly an Importer), we can support you as well.
This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.
“It's Class IIa because our competitor is Class IIa” isn't a classification rationale.
Early assumptions about qualification, classification and conformity assessment can influence testing, clinical strategy, budget and Notified Body involvement.
Those assumptions should therefore be challenged and properly documented before they become expensive to change.
3. Use the GSPR to Build the Dossier
The GSPR shouldn't simply appear at the end of the project as another checklist.
For every applicable requirement, ask:
How will we demonstrate conformity?
That means identifying the relevant standard, specification, analysis, test or report—and determining whether the required evidence actually exists.
Used this way, the GSPR becomes a tool for building Technical Documentation and identifying evidence gaps early.
4. Available Doesn't Mean Adequate
One of the biggest mistakes in Technical Documentation gap assessments is asking only:
“Do we have this document?”
A better question is:
“Is this evidence adequate for the device we're certifying?”
A biocompatibility report may exist—but does it cover the same materials, manufacturing process, patient-contacting components and contact duration?
Software verification may exist—but does it cover the current software version?
Clinical evidence may exist—but does it support the current intended purpose and claims?
That's why Available, Applicable and Adequate are three different things.
5. Make Sure the Puzzle Fits
Before submission, consistency and traceability become critical.
Imagine the IFU says the device can be used for seven days, while the Risk Management File and biological evaluation assume only 24 hours.
Every document exists—but together they don't tell a coherent story.
A reviewer should be able to trace important claims through intended purpose, design requirements, verification, clinical evidence, risk management, labeling and PMS.
Likewise, important risks should connect logically to risk controls, design implementation, verification, residual risk and post-market monitoring.
The 80/20 Approach to Technical Documentation
Instead of focusing first on the number of documents completed, focus on five questions:
Do we understand the product and its claims? Is our regulatory strategy defensible? Have requirements been translated into evidence needs? Is our evidence adequate? Does everything tell the same story?
Strong foundations make the rest of Technical Documentation much easier to structure.
EMD Technical Documentation Roadmap
To support this process, Easy Medical Device created the EMD Technical Documentation Roadmap.
The tool provides a structure for understanding the product, documenting regulatory strategy, mapping requirements, identifying standards and guidance, connecting risks with evidence, assessing gaps, assigning responsibilities, performing consistency checks, and ultimately mapping the documentation into Annex II and Annex III.
Final Takeaway
Stop thinking about Technical Documentation as a collection of folders that need to be filled.
Think about what the reviewer needs to understand:
Is there sufficient, coherent evidence demonstrating that this device conforms with the applicable requirements?
Your Technical Documentation isn't a filing cabinet.
Easy Medical Device Services
CE Marking • MDR • IVDR • Technical Documentation
Medical Device Market Access Services – Easy Medical Device
This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.
🇨🇭 swissdamed Registration Becomes Mandatory
Swissmedic – swissdamed Registration Obligation
From 1 July 2026, manufacturers and authorised representatives must register relevant devices, systems, and procedure packs in the swissdamed UDI Devices module.
The general transition period ends on 31 December 2026, making data preparation, responsibility allocation, and reconciliation important operational priorities for companies active in Switzerland.
🇬🇧 MHRA Guidance on Ambient Voice Technology
Read the MHRA Guidance
The MHRA provides useful clarification on when ambient voice technologies, including clinical scribes, may fall within medical device regulation.
Pure transcription or clinician-reviewed administrative summaries may remain outside medical device qualification, while diagnostic insights, treatment recommendations, or medical-performance claims can create a medical intended purpose.
🇺🇸 FDA FY 2027 Medical Device User Fees
FDA FY 2027 Medical Device User Fees
FDA published its FY 2027 medical device user fee notice, covering submission fees, establishment registration, small-business reductions, and related payment procedures.
The new fee year applies from 1 October 2026 through 30 September 2027, making the actual submission receipt date an important consideration when planning budgets.
One important message for global manufacturers is that an EU or US classification rationale shouldn't simply be reused without mapping the device and evidence to the Indian framework.
🇸🇬 Singapore Updates Medical Device Cybersecurity Guidance
Singapore HSA Medical Device Guidance
Singapore HSA published an updated Best Practices Guide on Medical Device Cybersecurity in August 2026.
For connected medical devices and software manufacturers, it provides another useful benchmark for secure development, vulnerability management, updates, and post-market cybersecurity activities.
📅 Stay Updated on MedTech Events
Explore MedTech Conferences & Events on MedTechConf
The episode also highlights upcoming opportunities covering Article 117, MDR/IVDR, biocompatibility, AI, clinical evidence, PMS, vigilance, digital health, and African medical device regulation.
🎙️ Continue Learning with Easy Medical Device
Explore the Easy Medical Device Podcast
The July and August catalogue covers audit readiness, FDA clearance, risk management, QMS effectiveness, Intended Use, Master UDI-DI, Verification & Validation, DHF remediation, and global market access.
Easy Medical Device Services
CE Marking • MDR • IVDR • Technical Documentation
Medical Device Market Access Services – Easy Medical Device
This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.
The objective isn't simply to create more documentation. It's to create a coherent and traceable design history.
IMDRF, Regulatory Reliance and Global Market Access
Once a device is ready for market, manufacturers face another challenge: navigating multiple regulatory systems around the world.
The International Medical Device Regulators Forum (IMDRF) plays an important role in encouraging greater regulatory convergence internationally.
Regulatory reliance takes this concept further by allowing authorities, where applicable, to leverage assessments or decisions from other trusted regulatory authorities rather than unnecessarily duplicating the entire review process.
For manufacturers seeking international expansion, understanding these developments can become an important part of building an efficient global market access strategy.
Connecting the Entire Journey
These three topics may appear separate, but they represent a logical progression:
Verification & Validation → Design Documentation → Global Regulatory Approvals
First, manufacturers need evidence that the device performs as expected.
Then, they need documentation that clearly demonstrates how the device was developed and controlled.
Finally, they need a regulatory strategy capable of bringing that device into different markets.
For MedTech companies, getting these elements right can create a stronger foundation for compliance, regulatory submissions, and international market access.
A successful regulatory journey doesn't begin with the submission—it begins with how the device is designed, tested, documented, and prepared for the markets it intends to enter.
Who is Monir El Azzouzi?
Monir El Azzouzi is the founder and CEO of Easy Medical Device a Consulting firm that is supporting Medical Device manufacturers for any Quality and Regulatory affairs activities all over the world. Monir can help you to create your Quality Management System, Technical Documentation or he can also take care of your Clinical Evaluation, Clinical Investigation through his team or partners. Easy Medical Device can also become your Authorized Representative and Independent Importer Service provider for EU, UK and Switzerland.
Monir has around 16 years of experience within the Medical Device industry working for small businesses and also big corporate companies. He has now supported around 100 clients to remain compliant on the market. His passion to the Medical Device filed pushed him to create educative contents like, blog, podcast, YouTube videos, LinkedIn Lives where he invites guests who are sharing educative information to his audience. Visit easymedicaldevice.com to know more. If you need help implementing QMSR or preparing your teams for FDA inspections, contact: info@easymedicaldevice.com
If you are located outside the EU/UK/Switzerland and need an Authorized Representative (and possibly an Importer), we can support you as well.
This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.
Understanding how it fits into the broader UDI framework can help manufacturers prepare their documentation and data strategy while avoiding mistakes that could create additional regulatory or operational work later.
Building a Stronger Market Access Strategy
Although Intended Use and Master UDI-DI address different regulatory challenges, they share an important principle: regulatory strategy should be considered early rather than treated as an administrative task at the end of development.
Clearly defining your device, understanding its regulatory implications, and preparing the right identification strategy can help create a more predictable path toward market access.
For Regulatory Affairs professionals and medical device manufacturers, these conversations provide practical insights into two topics that can significantly influence the regulatory journey from product development to market.
Who is Monir El Azzouzi?
Monir El Azzouzi is the founder and CEO of Easy Medical Device a Consulting firm that is supporting Medical Device manufacturers for any Quality and Regulatory affairs activities all over the world. Monir can help you to create your Quality Management System, Technical Documentation or he can also take care of your Clinical Evaluation, Clinical Investigation through his team or partners. Easy Medical Device can also become your Authorized Representative and Independent Importer Service provider for EU, UK and Switzerland.
Monir has around 16 years of experience within the Medical Device industry working for small businesses and also big corporate companies. He has now supported around 100 clients to remain compliant on the market. His passion to the Medical Device filed pushed him to create educative contents like, blog, podcast, YouTube videos, LinkedIn Lives where he invites guests who are sharing educative information to his audience. Visit easymedicaldevice.com to know more. If you need help implementing QMSR or preparing your teams for FDA inspections, contact: info@easymedicaldevice.com
If you are located outside the EU/UK/Switzerland and need an Authorized Representative (and possibly an Importer), we can support you as well.
This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.
That's the core of the “fake QMS” problem: the documented system and the way the company actually operates become two different systems.
During an audit, this gap can quickly become visible.
Building a QMS That Actually Works
An effective QMS should be integrated into everyday operations rather than maintained only for certification or audits.
Problems should be identified and evaluated appropriately. Customer feedback should feed into complaint handling and post-market activities. Significant and recurring issues should trigger investigation, and lessons learned should contribute to continuous improvement.
Ultimately, the goal isn't to create a perfect-looking Quality Management System.
The goal is to create a QMS that helps your organization consistently identify problems, manage risk, improve processes, and support the delivery of safe and effective medical devices.
Who is Monir El Azzouzi?
Monir El Azzouzi is the founder and CEO of Easy Medical Device a Consulting firm that is supporting Medical Device manufacturers for any Quality and Regulatory affairs activities all over the world. Monir can help you to create your Quality Management System, Technical Documentation or he can also take care of your Clinical Evaluation, Clinical Investigation through his team or partners. Easy Medical Device can also become your Authorized Representative and Independent Importer Service provider for EU, UK and Switzerland.
Monir has around 16 years of experience within the Medical Device industry working for small businesses and also big corporate companies. He has now supported around 100 clients to remain compliant on the market. His passion to the Medical Device filed pushed him to create educative contents like, blog, podcast, YouTube videos, LinkedIn Lives where he invites guests who are sharing educative information to his audience. Visit easymedicaldevice.com to know more. If you need help implementing QMSR or preparing your teams for FDA inspections, contact: info@easymedicaldevice.com
If you are located outside the EU/UK/Switzerland and need an Authorized Representative (and possibly an Importer), we can support you as well.
This podcast is hosted by Podcastics, the easiest platform to create and publish your podcast.
Podcasts Similaires Basées sur le Contenu
Découvrez des podcasts liées à Medical Device made Easy Podcast. Explorez des podcasts avec des thèmes, sujets, et formats similaires. Ces similarités sont calculées grâce à des données tangibles, pas d'extrapolations !
